Number of Shares
236,366.00
Current Holdings Value*
kr16.38 Mil
% of Portfolio
1.86%
Total Estimate Gain
kr151.93 Mil
% of Total Estimate Gain
142.87%

Research International Core Portfolio's Novo Nordisk AS Holding Summary

As of 2025-03-31, NORTHWESTERN MUTUAL SERIES FUND INC held 236,366.00 shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr16.38 Mil. This investment constitutes 1.86% of their stock portfolio, and NORTHWESTERN MUTUAL SERIES FUND INC now holds 0.01% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2019Q3. And since then Research International Core Portfolio has made 7 purchases of OCSE:NOVO B, at an average price of kr178.34, for a total of 596,287.00 shares. In addition, there have been 10 sales at an average price of kr445.29 for 359,921.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr414.60, Research International Core Portfolio's estimated gain on his OCSE:NOVO B holdings is kr151.93 Mil, reflecting a 142.87% gain to date.

Research International Core Portfolio OCSE:NOVO B (kr414.60) Holding Chart

Research International Core Portfolio OCSE:NOVO B (kr414.60) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1